| scholarly article | Q13442814 |
| P2093 | author name string | Keith W Dilly | |
| Silvia Guatimosim | |||
| W Jonathan Lederer | |||
| Kin M Choi | |||
| Brian D Hoit | |||
| Yan Zhong | |||
| Ingrid L Grupp | |||
| Harvey Hahn | |||
| Mohammed A Matlib | |||
| P2860 | cites work | Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation | Q28509802 |
| Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality | Q31920931 | ||
| Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q33728882 | ||
| Cellular and functional defects in a mouse model of heart failure | Q33925912 | ||
| Cardiac intracellular calcium release channels: role in heart failure | Q33960297 | ||
| Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. | Q34060513 | ||
| New type of cardiomyopathy associated with diabetic glomerulosclerosis | Q34205051 | ||
| Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes | Q34464960 | ||
| The control of calcium release in heart muscle | Q36703939 | ||
| Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. | Q36881477 | ||
| Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation | Q37307370 | ||
| Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice | Q37350650 | ||
| Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy | Q37385438 | ||
| Diabetes and thyroid-hormone-induced changes in cardiac function and their molecular basis | Q38639872 | ||
| Phospholamban: a prominent regulator of myocardial contractility | Q40919889 | ||
| Intracellular calcium levels are unchanged in the diabetic heart | Q41526727 | ||
| Cytosolic Ca2+ concentration decreases in diabetic rat myocytes | Q41526737 | ||
| Transgenic approaches to define the functional role of dual site phospholamban phosphorylation | Q42450966 | ||
| Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart | Q42521720 | ||
| Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts | Q43713882 | ||
| Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy | Q43935483 | ||
| Role of diabetes in congestive heart failure: the Framingham study | Q44758886 | ||
| Sarcoplasmic reticulum in heart failure: central player or bystander? | Q48008693 | ||
| Alterations of calcium-regulatory proteins in heart failure | Q48008757 | ||
| Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study) | Q57604699 | ||
| P433 | issue | 4 | |
| P921 | main subject | cardiomyopathy | Q847583 |
| P304 | page(s) | H1398-408 | |
| P577 | publication date | 2002-06-27 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats | |
| P478 | volume | 283 |
| Q37983012 | A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy |
| Q34815218 | ACE-inhibition, but not weight reduction restores cardiomyocyte response to β-adrenergic stimulation in the metabolic syndrome. |
| Q36193769 | Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling |
| Q43154490 | Alloxan reduces amplitude of ventricular myocyte shortening and intracellular Ca2+ without altering L-type Ca2+ current, sarcoplasmic reticulum Ca2+ content or myofilament sensitivity to Ca2+ in Wistar rats |
| Q38309620 | Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance |
| Q39897078 | Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy |
| Q36807692 | Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. |
| Q35940006 | Altered cardiac calcium handling in diabetes |
| Q42584147 | Altered mechanical and electrical activities of the diabetic heart: Possible use of new therapeutics? |
| Q38653843 | Altered profile of mRNA expression in atrioventricular node of streptozotocin‑induced diabetic rats. |
| Q37707579 | Angiogenic microenvironment augments impaired endothelial responses under diabetic conditions |
| Q38705779 | Arrhythmia Vulnerability in Diabetic Cardiac Tissue is Species-Dependent: Effects of I KATP, Uncoupling, and Connexin Lateralization |
| Q52660233 | Attenuation of Ca2+ homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise? |
| Q35602720 | Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis |
| Q55049902 | Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat. |
| Q44643876 | Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study |
| Q28577628 | Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes |
| Q36174773 | Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus. |
| Q42498213 | Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat. |
| Q46526700 | Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats |
| Q43138069 | Characterization of L-type calcium channel activity in atrioventricular nodal myocytes from rats with streptozotocin-induced Diabetes mellitus |
| Q46856995 | Characterization of alterations in diabetic myocardial tissue using high resolution MRI. |
| Q92852811 | Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy |
| Q33357265 | Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria |
| Q80114788 | Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats |
| Q34271053 | Diabetes alters intracellular calcium transients in cardiac endothelial cells |
| Q33804265 | Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation |
| Q26997062 | Diabetic cardiomyopathy: bench to bedside |
| Q28395852 | Diabetic cardiomyopathy: signaling defects and therapeutic approaches |
| Q51315241 | Disbalance of calcium regulation-related genes in broiler hearts induced by selenium deficiency. |
| Q51434807 | Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome. |
| Q45054948 | Effects of acidosis on ventricular myocyte shortening and intracellular Ca2+ in streptozotocin-induced diabetic rats |
| Q83047821 | Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat |
| Q42478151 | Effects of exercise training combined with insulin treatment on cardiac NOS1 signaling pathways in type 1 diabetic rats |
| Q22241401 | Effects of gender difference on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats |
| Q45054945 | Effects of halothane, isoflurane, sevoflurane and desflurane on contraction of ventricular myocytes from streptozotocin-induced diabetic rats |
| Q93167935 | Effects of prolactin on ventricular myocyte shortening and calcium transport in the streptozotocin-induced diabetic rat |
| Q46400011 | Effects of single high-dose and multiple low-dose streptozotocin on contraction and intracellular Ca2+ in ventricular myocytes from diabetes resistant and susceptible rats |
| Q80413608 | Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart |
| Q46482196 | Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle |
| Q46540837 | Effects of varying intensity exercise on shortening and intracellular calcium in ventricular myocytes from streptozotocin (STZ)-induced diabetic rats |
| Q39670528 | Electrophysiological basis of metabolic-syndrome-induced cardiac dysfunction. |
| Q36078945 | Emerging beneficial roles of sirtuins in heart failure. |
| Q37125035 | Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes |
| Q64076654 | Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats |
| Q46725830 | Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats |
| Q37858336 | Endoplasmic-reticulum calcium depletion and disease |
| Q30301118 | Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling |
| Q36312605 | Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. |
| Q37233149 | Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation |
| Q37223281 | Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia |
| Q28389901 | Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes |
| Q44559061 | Gender differences in myosin heavy chain-beta and phosphorylated phospholamban in diabetic rat hearts |
| Q45054957 | Halothane alters contractility and Ca2+ transport in ventricular myocytes from streptozotocin-induced diabetic rats |
| Q35134241 | Heart disease in diabetic patients |
| Q39763308 | Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. |
| Q64375151 | Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo |
| Q49989710 | Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats |
| Q47943096 | In vivo imaging of intracellular Ca2+ after muscle contractions and direct Ca2+ injection in rat skeletal muscle in diabetes |
| Q55399483 | Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. |
| Q43059618 | Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy |
| Q42503082 | Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes |
| Q81565816 | Interpretation of relevance of sodium-calcium exchange in action potential of diabetic rat heart by mathematical model |
| Q42517698 | Intracellular levels of Na(+) and TTX-sensitive Na(+) channel current in diabetic rat ventricular cardiomyocytes |
| Q51022158 | Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. |
| Q46642906 | Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. |
| Q35072110 | Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. |
| Q34708259 | Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis |
| Q36485424 | Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes |
| Q36699924 | Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes |
| Q38084193 | Mechanisms of subcellular remodeling in heart failure due to diabetes |
| Q38234562 | Mechanisms underlying the impaired contractility of diabetic cardiomyopathy. |
| Q35057592 | Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. |
| Q53645124 | Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart. |
| Q35885059 | Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review |
| Q35221216 | Myocardial performance in conscious streptozotocin diabetic rats |
| Q46592819 | Myofilament sensitivity to Ca2+ in ventricular myocytes from the Goto-Kakizaki diabetic rat. |
| Q36176127 | Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway |
| Q38196172 | Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease |
| Q47763435 | Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy |
| Q58693859 | Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity |
| Q37710547 | Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy |
| Q37360093 | Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats |
| Q43223828 | Protective action of doxycycline against diabetic cardiomyopathy in rats |
| Q37748612 | Protective role of antioxidants in diabetes-induced cardiac dysfunction |
| Q37088282 | Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. |
| Q45059479 | QRS/T-wave and calcium alternans in a type I diabetic mouse model for spontaneous postmyocardial infarction ventricular tachycardia: A mechanism for the antiarrhythmic effect of statins |
| Q26849625 | Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart |
| Q37710964 | Regional effects of streptozotocin-induced diabetes on shortening and calcium transport in epicardial and endocardial myocytes from rat left ventricle. |
| Q42502118 | Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. |
| Q33727613 | Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy |
| Q46938364 | Sarcoplasmic Ca2+ release is prolonged in nonfailing myocardium of diabetic patients |
| Q46743940 | Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle |
| Q45216941 | Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. |
| Q35130314 | Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. |
| Q52572090 | Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat. |
| Q37734628 | Streptozotocin-induced diabetes prolongs twitch duration without affecting the energetics of isolated ventricular trabeculae. |
| Q28582099 | Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression |
| Q51542054 | The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling. |
| Q52146506 | The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus. |
| Q51389323 | The chronic effects of neonatal alloxan-induced diabetes mellitus on ventricular myocyte shortening and cytosolic Ca2+ |
| Q37215457 | The complexities of diabetic cardiomyopathy: lessons from patients and animal models |
| Q46597569 | The progressive effects of a fat enriched diet on ventricular myocyte contraction and intracellular Ca2+ in the C57BL/6J mouse |
| Q37101642 | Trace elements in diabetic cardiomyopathy: An electrophysiological overview |
| Q45054950 | Voltage-dependence of contraction in streptozotocin-induced diabetic myocytes |
| Q34907705 | ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart |
Search more.